Elizabeth Weesner, Hosain Ghassemi, Iryna Salapenka, Jaya Sri Konakanchi, Gregory Maggio, and Roopa Sethi. “Injection Site Reaction to Extended-Release Buprenorphine (Sublocade®) for Opioid Use Disorder Fourteen Days After Administration”. Kansas Journal of Medicine 15, no. 2 (August 22, 2022): 302–304. Accessed May 7, 2024. https://journals.ku.edu/kjm/article/view/17931.